The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial

Teunissen Jasmijn, Hochs Anne H.J., Vaessen-Verberne Anja, Boehmer Annemie L.M., Smeets Carien C.J.M., Brackel Hein, van Gent René, Wesseling Judith, Logtens-Stevens Danielle, de Moor Ronald, Rosias Philippe P.R., Potgieter Steph, Faber Marianne R., Hendriks Han J.E., Janssen-Heijnen Maryska L.G., Loza Bettina F.

Source: Eur Respir J 2014; 44: 913-921
Journal Issue: October
Disease area: Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Teunissen Jasmijn, Hochs Anne H.J., Vaessen-Verberne Anja, Boehmer Annemie L.M., Smeets Carien C.J.M., Brackel Hein, van Gent René, Wesseling Judith, Logtens-Stevens Danielle, de Moor Ronald, Rosias Philippe P.R., Potgieter Steph, Faber Marianne R., Hendriks Han J.E., Janssen-Heijnen Maryska L.G., Loza Bettina F.. The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial. Eur Respir J 2014; 44: 913-921

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nebulised hypertonic (7%) saline improves quality of life in a blinded randomised cross-over trial
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS)
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018



Double blind randomised placebo controlled study of effect of inhalation of (72% O2 and 28% helium) on perception of methacholine induced breathlessness in asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008


A single blind study to compare nebulised hypertonic saline (7%) and normal saline (0.9%) as an adjunct to physiotherapy airway clearance in patients with bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 304s
Year: 2005

Randomized, double blind, double dummy, placebo-controlled trial designed for comparing the effectiveness of formoterol (Foradil®) Aerolizer® and ipatropium bromide plus nebulized fenoterol (Berodual®) in asthma patients with ages ranging between 5 and 12 years who suffer acute asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012

BT10+ study design: 10 year follow-up of subjects receiving bronchial thermoplasty (BT) in 3 randomized controlled studies
Source: International Congress 2017 – To freeze or heat?
Year: 2017


A randomised, double-blind, placebo-controlled phase 3 study investigating the efficacy of nicotine substitution (NS) on nicotine withdrawal symptoms (NWS) in hospitalised smokers (HS)
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


The effect of high dose N-acetylcysteine (1200mg daily) on airway function and airway trapping in COPD patients — A double blinded randomized placebo controlled trial
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012


A double-blind trial of hyperosmolar saline as an adjunt to phsiotherapy in patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001

RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021



A randomised controlled trial on the effect of inhaled hypertonic saline on quality of life in primary ciliary dyskinesia
Source: Eur Respir J , 49 (2) 1601770; DOI: 10.1183/13993003.01770-2016
Year: 2017



Randomized clinical trial (RCT) comparing formoterol vs. salbutamol plus ipratropium bromide in the treatment of acute asthma exacerbation (AE) at emergency room (ER)
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005

Fixed combination of glycopyrrolate and formoterol MDI (GFF-MDI) demonstrates superior inspiratory capacity (IC) compared to tiotropium DPI (Tio) following 7 days dosing, in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011

Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment
Year: 2018




Whole body vibration training in long-term (>1 year) lung transplant patients – A randomized, controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Double-blind placebo controlled randomized trial of montelukast in acute RSV bronchiolitis
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Comparison against baseline in randomised control trials (again)
Source: Eur Respir J 2014; 44: 1376
Year: 2014


Comparison against baseline in randomised control trials (again)
Source: Eur Respir J 2014; 44: 1376-1377
Year: 2014